Chinthalapally V. Rao
Affiliations: | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Pathology, Oncology, Cell BiologyGoogle:
"Chinthalapally Rao"Children
Sign in to add traineeDurgadevi Ravillah | grad student | 2013 | University of Oklahoma Health Sciences Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Madka V, Patlolla JMR, Venkatachalam K, et al. (2023) Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats. Cancers. 15 |
Madka V, De La Cruz A, Pathuri G, et al. (2022) Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the mouse model. American Journal of Cancer Research. 12: 2118-2131 |
Kumar G, Madka V, Pathuri G, et al. (2021) Molecular Mechanisms of Cancer Prevention by Gooseberry (). Nutrition and Cancer. 1-12 |
Madka V, Kumar G, Pathuri G, et al. (2021) Proton pump inhibitor omeprazole suppresses carcinogen induced colonic adenoma progression to adenocarcinoma in F344 rat. Cancer Prevention Research (Philadelphia, Pa.) |
Kumar G, Madka V, Singh A, et al. (2021) Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras mice. Neoplasia (New York, N.Y.). 23: 574-583 |
Xiong X, Rao G, Roy RV, et al. (2020) Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
Panneerselvam J, Mohandoss P, Patel R, et al. (2020) DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4. Molecular Therapy Oncolytics. 18: 24-36 |
Chandrakesan P, Panneerselvam J, May R, et al. (2020) DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization. Molecular Cancer Therapeutics |
Yarla NS, Pathuri G, Gali H, et al. (2020) Abstract 6364: LFA-9, a dual mPGES-1 and 5-LOX inhibitor, suppresses colon cancer stemness and inflammogen-induced inflammatory response Cancer Research. 80: 6364-6364 |
Chandrakesan P, Panneerselvam J, Qu D, et al. (2020) Abstract 3829: Dclk1 expressing crypt epithelial cells become tumor initiating stem cells in an inflammation associated environment Tumor Biology |